Tugan Bese

Istanbul, 34153, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Retrospective Multicenter Analysis of Malignant Struma Ovarii: Clinical Characteristics, Management, and Outcomes.

Retrospective Multicenter Analysis of Malignant Struma Ovarii: Clinical Characteristics, Management, and Outcomes.

Journal: Journal of clinical medicine

Published: November 07, 2025

Assessing the predictive value of the American College of Surgeons National Surgical Quality Improvement Program surgical risk model in a high-volume gynecologic oncology center in Turkey: a retrospective cohort study.

Assessing the predictive value of the American College of Surgeons National Surgical Quality Improvement Program surgical risk model in a high-volume gynecologic oncology center in Turkey: a retrospective cohort study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 05, 2025

Clinicopathologic and recurrence characteristics of leiomyoma with bizarre nuclei, which is rare type of uterine smooth macule tumors.

Clinicopathologic and recurrence characteristics of leiomyoma with bizarre nuclei, which is rare type of uterine smooth macule tumors.

Journal: Ginekologia polska

Published: April 02, 2025

The Effect of Neutrophil-to-Lymphocyte Ratio on Prognosis in Malignant Ovarian Germ Cell Tumors.

The Effect of Neutrophil-to-Lymphocyte Ratio on Prognosis in Malignant Ovarian Germ Cell Tumors.

Journal: Diagnostics (Basel, Switzerland)

Published: March 24, 2025

The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.

The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.

Journal: Journal of gynecologic oncology

Published: January 14, 2025

Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN removal: Turkish Gynecologic Oncology Group (TRSGO-SLN-009).

Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN removal: Turkish Gynecologic Oncology Group (TRSGO-SLN-009).

Journal: Journal of gynecologic oncology

Published: November 11, 2024

Risk factors for the involvement of sentinel lymph nodes in endometrial cancer (TRSGO-SLN-010).

Risk factors for the involvement of sentinel lymph nodes in endometrial cancer (TRSGO-SLN-010).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 21, 2024

Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study.

Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 05, 2024

Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Khatib et al.

Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Khatib et al.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 07, 2024

Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.

Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.

Journal: Journal of gynecologic oncology

Published: February 25, 2024

The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.

The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: November 03, 2023

3-4 Cycles versus 6 Cycles Neoadjuvant Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: Survival Is Not Determined by the Number of Neoadjuvant Chemotherapy Cycles.

3-4 Cycles versus 6 Cycles Neoadjuvant Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: Survival Is Not Determined by the Number of Neoadjuvant Chemotherapy Cycles.

Journal: Chemotherapy

Published: September 08, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026